Lumakras
Chemical Name | sotorasib |
Dosage Form | Tablet (oral; 120 mg) |
Drug Class | Inhibitors |
System | Respiratory |
Company | Amgen |
Approval Year | 2021 |
Indication
- For the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test, who have received at least one prior systemic therapy